Financial Counselors Inc’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,829
| Closed | -$2.83M | – | 118 |
|
|
2025
Q1 | $2.83M | Sell |
18,829
-16,884
| -47% | -$2.54M | 0.04% | 240 |
|
|
2024
Q4 | $6.59M | Buy |
35,713
+9,121
| +34% | +$1.68M | 0.1% | 174 |
|
|
2024
Q3 | $5.24M | Buy |
26,592
+4,896
| +23% | +$964K | 0.08% | 191 |
|
|
2024
Q2 | $4.48M | Buy |
21,696
+555
| +3% | +$115K | 0.07% | 195 |
|
|
2024
Q1 | $5.73M | Sell |
21,141
-19
| -0.1% | -$5.15K | 0.1% | 179 |
|
|
2023
Q4 | $5M | Sell |
21,160
-1,405
| -6% | -$332K | 0.09% | 182 |
|
|
2023
Q3 | $4.42M | Buy |
22,565
+992
| +5% | +$194K | 0.09% | 183 |
|
|
2023
Q2 | $4.54M | Sell |
21,573
-1,162
| -5% | -$244K | 0.09% | 180 |
|
|
2023
Q1 | $4.59M | Sell |
22,735
-3,624
| -14% | -$731K | 0.1% | 172 |
|
|
2022
Q4 | $5.74M | Sell |
26,359
-1,177
| -4% | -$256K | 0.13% | 159 |
|
|
2022
Q3 | $5.42M | Buy |
27,536
+2,986
| +12% | +$588K | 0.13% | 153 |
|
|
2022
Q2 | $5.25M | Buy |
24,550
+750
| +3% | +$160K | 0.12% | 162 |
|
|
2022
Q1 | $6.76M | Buy |
23,800
+1,462
| +7% | +$415K | 0.14% | 152 |
|
|
2021
Q4 | $8.42M | Buy |
22,338
+2,249
| +11% | +$847K | 0.17% | 145 |
|
|
2021
Q3 | $8.29M | Sell |
20,089
-2,222
| -10% | -$917K | 0.18% | 142 |
|
|
2021
Q2 | $8.25M | Buy |
22,311
+377
| +2% | +$139K | 0.18% | 142 |
|
|
2021
Q1 | $6.36M | Buy |
21,934
+4,309
| +24% | +$1.25M | 0.15% | 154 |
|
|
2020
Q4 | $4.4M | Buy |
17,625
+855
| +5% | +$214K | 0.11% | 177 |
|
|
2020
Q3 | $3.8M | Buy |
16,770
+697
| +4% | +$158K | 0.11% | 177 |
|
|
2020
Q2 | $2.8M | Buy |
16,073
+2,739
| +21% | +$477K | 0.09% | 200 |
|
|
2020
Q1 | $1.68M | Buy |
13,334
+5,245
| +65% | +$662K | 0.07% | 206 |
|
|
2019
Q4 | $1.24M | Buy |
8,089
+3,684
| +84% | +$563K | 0.04% | 261 |
|
|
2019
Q3 | $583K | Buy |
+4,405
| New | +$583K | 0.02% | 324 |
|